Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1904 1
1910 1
1957 1
1993 3
1994 1
1999 1
2000 1
2001 1
2003 1
2004 2
2006 1
2008 3
2010 1
2011 4
2012 3
2013 4
2016 1
2018 1
2020 2
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Laser Control of Electronic Exchange Interaction within a Molecule.
Rupprecht P, Aufleger L, Heinze S, Magunia A, Ding T, Rebholz M, Amberg S, Mollov N, Henrich F, Haverkort MW, Ott C, Pfeifer T. Rupprecht P, et al. Among authors: amberg s. Phys Rev Lett. 2022 Apr 15;128(15):153001. doi: 10.1103/PhysRevLett.128.153001. Phys Rev Lett. 2022. PMID: 35499899
Lassa antiviral LHF-535 protects guinea pigs from lethal challenge.
Cashman KA, Wilkinson ER, Posakony J, Madu IG, Tarcha EJ, Lustig KH, Korth MJ, Bedard KM, Amberg SM. Cashman KA, et al. Among authors: amberg sm. Sci Rep. 2022 Nov 19;12(1):19911. doi: 10.1038/s41598-022-23760-2. Sci Rep. 2022. PMID: 36402782 Free PMC article.
Amberg S. Amberg S. J Exp Med. 1910 Jul 23;12(4):435-59. doi: 10.1084/jem.12.4.435. J Exp Med. 1910. PMID: 19867336 Free PMC article.
A potent Lassa virus antiviral targets an arenavirus virulence determinant.
Madu IG, Files M, Gharaibeh DN, Moore AL, Jung KH, Gowen BB, Dai D, Jones KF, Tyavanagimatt SR, Burgeson JR, Korth MJ, Bedard KM, Iadonato SP, Amberg SM. Madu IG, et al. Among authors: amberg sm. PLoS Pathog. 2018 Dec 21;14(12):e1007439. doi: 10.1371/journal.ppat.1007439. eCollection 2018 Dec. PLoS Pathog. 2018. PMID: 30576397 Free PMC article.
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Klement P, Fiedler W, Gabdoulline R, Dallmann LK, Wienecke CP, Schiller J, Kandziora C, Teich K, Heida B, Büttner K, Brandes M, Funke C, Wichmann M, Othman B, Chromik J, Amberg S, Kebenko M, Schlipfenbacher V, Wilke AC, Modemann F, Janning M, Serve H, Bokemeyer C, Theile S, Deppermann U, Kranich AL, Ganser A, Thol F, Heuser M. Klement P, et al. Among authors: amberg s. Ann Hematol. 2023 Feb;102(2):323-328. doi: 10.1007/s00277-022-05075-4. Epub 2022 Dec 28. Ann Hematol. 2023. PMID: 36576532 Free PMC article.
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Fiedler W, Chromik J, Amberg S, Kebenko M, Thol F, Schlipfenbacher V, Christine Wilke A, Modemann F, Janning M, Serve H, Ganser A, Bokemeyer C, Theile S, Deppermann U, Kranich AL, Heuser M. Fiedler W, et al. Among authors: amberg s. Br J Haematol. 2020 Aug;190(3):e169-e173. doi: 10.1111/bjh.16804. Epub 2020 Jun 9. Br J Haematol. 2020. PMID: 32515072 Free article. Clinical Trial. No abstract available.
35 results